OraSure - Public Comps and Valuation Multiples

OraSure Overview

About OraSure

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

Founded

2000

HQ

Employees

501

Website

orasure.com

Sectors

Medical Devices
Laboratory Services
DeepTech
HealthTech

Financials

LTM Revenue $171M

LTM EBITDA -$2.0M

EV

-$20.7M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

OraSure Financials

OraSure has a last 12-month revenue of $171M and a last 12-month EBITDA of -$2.0M.

In the most recent fiscal year, OraSure achieved revenue of $186M and an EBITDA of -$13.6M.

OraSure expects next 12-month revenue of XXX and NTM EBITDA of XXX

See OraSure valuation multiples based on analyst estimates

OraSure P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$405M	$186M	XXX	XXX	XXX
Gross Profit	$148M	$172M	XXX	XXX	XXX
Gross Margin	36%	92%	XXX	XXX	XXX
EBITDA	$64.4M	-$13.6M	XXX	XXX	XXX
EBITDA Margin	16%	-7%	XXX	XXX	XXX
Net Profit	-$17.9M	$53.7M	XXX	XXX	XXX
Net Margin	-4%	29%	XXX	XXX	XXX
Net Debt	n/a	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

OraSure Stock Performance

As of April 15, 2025, OraSure's stock price is $3.

OraSure has current market cap of $232M, and EV of -$20.7M.

See OraSure trading valuation data

OraSure Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
-$20.7M	$232M	XXX	XXX	XXX	XXX	$-0.33

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

OraSure Valuation Multiples

As of April 15, 2025, OraSure has market cap of $232M and EV of -$20.7M.

OraSure's trades at -0.1x LTM EV/Revenue multiple, and 10.2x LTM EBITDA.

Analysts estimate OraSure's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for OraSure and 10K+ public comps

OraSure Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	-$20.7M	XXX	XXX	XXX
EV/Revenue	-0.1x	XXX	XXX	XXX
EV/EBITDA	1.5x	XXX	XXX	XXX
P/E	-11.9x	XXX	XXX	XXX
P/E/Growth	n/a	XXX	XXX	XXX
EV/FCF	-0.9x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get OraSure Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

OraSure Valuation Multiples

OraSure's NTM/LTM revenue growth is -20%

OraSure's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, OraSure's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate OraSure's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for OraSure and other 10K+ public comps

OraSure Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	-54%	XXX	XXX	XXX	XXX
EBITDA Margin	-7%	XXX	XXX	XXX	XXX
EBITDA Growth	-121%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	-27%	XXX	XXX	XXX	XXX
Revenue per Employee	$0.4M	XXX	XXX	XXX	XXX
Opex per Employee	$0.2M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	17%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	25%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	14%	XXX	XXX	XXX	XXX
Opex to Revenue	56%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry